论文部分内容阅读
Aim: Clinical attempts to reduce the cardiotoxicity of arsenic trioxide (ATO) without compromising its anticancer activities remain to be an unresolved issue.In this study, we determined whether Salvianolic acid B (Sal B) can protect against ATOinduced cardiac toxicity in vivo and increase the toxicity of ATO toward cancer cells.